Edesa Biotech Inc.

News & Events

Press Releases

In The Media

1. Edesa Biotech Reports Fiscal 3rd Quarter 2025 Results

   GlobeNewswire AUG 8, 2025 4:35 PM EDT
   TORONTO, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage bi...
   Read Article

2. Edesa Biotech Reports Fiscal 2nd Quarter 2025 Results

   GlobeNewswire MAY 14, 2025 4:15 PM EDT
   TORONTO, May 14, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage bio...
   Read Article

3. Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference

   GlobeNewswire APR 28, 2025 4:30 PM EDT
   TORONTO, April 28, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage b...
   Read Article

4. Edesa Biotech Announces Chief Financial Officer Transition

   GlobeNewswire APR 4, 2025 4:15 PM EDT
   TORONTO, April 04, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage b...
   Read Article

5. Edesa Biotech Reports Fiscal 1st Quarter 2025 Results

   GlobeNewswire FEB 14, 2025 4:15 PM EST
   TORONTO, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage bi...
   Read Article

6. Edesa Biotech Announces $15.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

   GlobeNewswire FEB 13, 2025 7:00 AM EST
   Financing led by Velan Capital with participation from new and existing healthcare-focused instit...
   Read Article

7. Edesa Biotech Reports Fiscal Year 2024 Results

   GlobeNewswire DEC 13, 2024 4:30 PM EST
   TORONTO, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage bi...
   Read Article

8. Edesa Biotech's Founder Makes Strategic Investment in the Company

   GlobeNewswire OCT 31, 2024 8:15 AM EDT
   TORONTO, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage bi...
   Read Article

9. Edesa Biotech Announces Upcoming Conference Schedule

   GlobeNewswire OCT 21, 2024 8:15 AM EDT
   TORONTO, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage bi...
   Read Article

10. BARDA Selects Edesa Biotech's Drug for U.S. Funded Platform Trial in General ARDS

    ACCESS Newswire JUN 24, 2024 8:20 AM EDT
    This Phase 2 clinical study will evaluate paridiprubart (EB05) in hospitalized patients with acut...
    Read Article